FEDERALUnknownHealthcareHealthcareLow
ACTINIUM PHARMACEUTICALS, INC.
bd_b89caff4d27bc30c · schema v1 · pii pii-v1
Full breach record for ACTINIUM PHARMACEUTICALS, INC. →Actinium Pharmaceuticals' Item 1C disclosure in its Form 10-K describes the company's cybersecurity risk management program, governance structure (CFO-led, board audit-committee oversight), use of third-party advisors, incident response policy, and cyber liability insurance. The filing explicitly states that to date the company has not experienced any material cybersecurity incident affecting operations or financial condition. No breach event is disclosed.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/1388320/000121390024028038/f10k2023_actinium.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Mar 29, 2024
- Raw hash
- bc1e6ce597d484dfa50b23964a59600b1aaf487b98e8f08466525b425d8db99d
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- ACTINIUM PHARMACEUTICALS, INC.norm: actinium pharmaceuticals
Victim entity
- Name
- ACTINIUM PHARMACEUTICALS, INC.norm: actinium pharmaceuticals
- SEC CIK
- 1388320
- Industry
- Healthcarellm
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.